Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y.-J.
Right arrow Articles by Park, Y.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.-J.
Right arrow Articles by Park, Y.-M.
[Cancer Research 66, 7136-7142, July 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Prx1 Suppresses Radiation-Induced c-Jun NH2-Terminal Kinase Signaling in Lung Cancer Cells through Interaction with the Glutathione S-Transferase Pi/c-Jun NH2-Terminal Kinase Complex

Yun-Jeong Kim1, Weon-Sup Lee1, Clement Ip2, Ho-Zoon Chae3, Eun-Mi Park1 and Young-Mee Park1

Departments of 1 Cell Stress Biology and 2 Cancer Prevention, Roswell Park Cancer Institute, Buffalo, New York and 3 Department of Biological Sciences, Chonnam National University, Kwangju, Korea

Requests for reprints: Young-Mee Park, Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-3190; Fax: 716-845-8899; E-mail: young-mee.park{at}roswellpark.org.

Radiotherapy is one of the major treatment modalities for lung cancer. Cell killing by ionizing radiation is mediated primarily through the reactive oxygen species (ROS) and ROS-driven oxidative stress. Prx1, a peroxiredoxin family member, was shown to be frequently elevated in lung cancer cells and tissues. Although the antioxidant function of Prx1 is expected to affect the radiotherapy response of lung cancer, the physiologic significance of its peroxidase activity in irradiated cells is unclear because the catalytic Cys52 is easily inactivated by ROS due to its overoxidation to sulfinic or sulfonic acid. In this study, we investigated the role of Prx1 in radiation sensitivity of human lung cancer cells, with special emphasis on the redox status of the catalytic Cys52. We found that overexpression of Prx1 enhances the clonogenic survival of irradiated cells and suppresses ionizing radiation–induced c-Jun NH2-terminal kinase (JNK) activation and apoptosis. The peroxidase activity of Prx1, however, is not essential for inhibiting JNK activation. The latter effect is mediated through its association with the glutathione S-transferase pi (GSTpi)-JNK complex, thereby preventing JNK release from the complex. Reduced JNK activation is observed when the peroxidase activity of Prx1 is compromised by Cys52 overoxidation or in the presence of the Cys52 to Ser52 mutant (Prx1C52S) lacking peroxidase activity. We show that both Prx1 and Prx1C52S interact with the GSTpi-JNK complex and suppress the release of JNK from the complex. Our study provides new insight into the antiapoptotic function of Prx1 in modulating radiosensitivity and provides the impetus to monitor the influence of Prx1 levels in the management of lung cancer. (Cancer Res 2006; 66(14): 7136-42)




This article has been cited by other articles:


Home page
CarcinogenesisHome page
I.-S. Song, S.-U. Kim, N.-S. Oh, J. Kim, D.-Y. Yu, S. M. Huang, J.-M. Kim, D.-S. Lee, and N.-S. Kim
Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells
Carcinogenesis, July 1, 2009; 30(7): 1106 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Wei, H. Jiang, C. P. Matthews, and N. H. Colburn
Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
PNAS, December 16, 2008; 105(50): 19738 - 19743.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Olahova, S. R. Taylor, S. Khazaipoul, J. Wang, B. A. Morgan, K. Matsumoto, T. K. Blackwell, and E. A. Veal
A redox-sensitive peroxiredoxin that is important for longevity has tissue- and stress-specific roles in stress resistance
PNAS, December 16, 2008; 105(50): 19839 - 19844.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-H. Kim, P. N. Bogner, S.-H. Baek, N. Ramnath, P. Liang, H.-R. Kim, C. Andrews, and Y.-M. Park
Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target
Clin. Cancer Res., April 15, 2008; 14(8): 2326 - 2333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. M. Lee, S. H. Park, D.-I. Shin, J.-Y. Hwang, B. Park, Y.-J. Park, T. H. Lee, H. Z. Chae, B. K. Jin, T. H. Oh, et al.
Oxidative Modification of Peroxiredoxin Is Associated with Drug-induced Apoptotic Signaling in Experimental Models of Parkinson Disease
J. Biol. Chem., April 11, 2008; 283(15): 9986 - 9998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Iraqui, G. Faye, S. Ragu, A. Masurel-Heneman, R. D. Kolodner, and M.-E. Huang
Human Peroxiredoxin PrxI Is an Orthologue of Yeast Tsa1, Capable of Suppressing Genome Instability in Saccharomyces cerevisiae
Cancer Res., February 15, 2008; 68(4): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. M. Townsend
S-Glutathionylation: Indicator of Cell Stress and Regulator of the Unfolded Protein Response
Mol. Interv., December 1, 2007; 7(6): 313 - 324.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. L. Holley, A. A. Fryer, J. W. Haycock, S. E.W. Grubb, R. C. Strange, and P. R. Hoban
Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis
Carcinogenesis, November 1, 2007; 28(11): 2268 - 2273.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-Y. Park, X. Yu, C. Ip, J. L. Mohler, P. N. Bogner, and Y.-M. Park
Peroxiredoxin 1 Interacts with Androgen Receptor and Enhances Its Transactivation
Cancer Res., October 1, 2007; 67(19): 9294 - 9303.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Lee, K.-S. Choi, J. Riddell, C. Ip, D. Ghosh, J.-H. Park, and Y.-M. Park
Human Peroxiredoxin 1 and 2 Are Not Duplicate Proteins: THE UNIQUE PRESENCE OF CYS83 IN Prx1 UNDERSCORES THE STRUCTURAL AND FUNCTIONAL DIFFERENCES BETWEEN Prx1 AND Prx2
J. Biol. Chem., July 27, 2007; 282(30): 22011 - 22022.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-H. Kim, P. N. Bogner, N. Ramnath, Y. Park, J. Yu, and Y.-M. Park
Elevated Peroxiredoxin 1, but not NF-E2-Related Factor 2, Is an Independent Prognostic Factor for Disease Recurrence and Reduced Survival in Stage I Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2007; 13(13): 3875 - 3882.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-J. Kim, J.-Y. Ahn, P. Liang, C. Ip, Y. Zhang, and Y.-M. Park
Human prx1 Gene Is a Target of Nrf2 and Is Up-regulated by Hypoxia/Reoxygenation: Implication to Tumor Biology
Cancer Res., January 15, 2007; 67(2): 546 - 554.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.